Improving follow-up care for cervical cancer in urban women
Official title: Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance
Run by Fox Chase Cancer Center · NCT06416150 · Data updated 2026-11-12
This study is testing a new text and phone coaching program to help urban women with cervical cancer get the follow-up care they need after abnormal test results.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | Women only |
| Enrollment | 546 (estimated) |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Locations | 3 sites (New Brunswick, New Jersey and 2 other locations) |
| Status | Recruiting |
| Started | August 28, 2024 |
| Main results expected | April 2027 |
| Study ends | December 2027 |
| Registry record updated | October 26, 2024 |
| Trial ID | NCT06416150 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 to 90 who have been referred for colposcopic evaluation and can communicate in English.
✕Probably not a fit
Patients who are currently pregnant, have a history of invasive cervical carcinoma, or require follow-up that does not involve a colposcopy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to reduce cervical cancer disparities by implementing the Health Enhancement Resource System (HERS), which provides text message-based counseling and telephone health coaching to women who miss follow-up appointments after abnormal cervical test results. The intervention is designed to increase patient follow-up rates and is based on a previously successful tailored communication approach. The study will be conducted at multiple urban clinic sites in Pennsylvania and New Jersey, utilizing a randomized trial design to assess the effectiveness of HERS in improving attendance at follow-up appointments.
Why it matters
Potential benefit: If successful, this intervention could significantly improve follow-up rates for cervical cancer screenings, ultimately reducing mortality rates in underserved urban populations.
How similar studies have gone: Previous studies have shown success with similar tailored communication interventions, indicating potential for this adapted approach to also be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites), * referral for colposcopic evaluation at the clinic sites, * able to communicate with ease in English, * have a cell phone with texting ability, and * competent to give consent. Exclusion Criteria: * are pregnant at the time of recruitment, * display current evidence or have a history of positive invasive carcinoma of the cervix, or * require follow-up but not a colposcopy.
Where it's running
-
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States Recruiting -
Thomas Jefferson University
Philadelphia, Pennsylvania, United States Recruiting -
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Suzanne M Miller, PhD — Fox Chase Cancer Center
- Study coordinator: Suzanne M Miller, PhD
- Email: suzanne.miller@fccc.edu
- Phone: 215-728-4069
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.